Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Bradford Wood and Baris Turkbey.
Bradford Wood
Connection Strength
5.278
Baris Turkbey
  1. AI-Assisted CT as a Clinical and Research Tool for COVID-19. Front Artif Intell. 2021; 4:590189.
    View in: PubMed
    Score: 0.239
  2. Correction to: CT and clinical assessment in asymptomatic and pre-symptomatic patients with early SARS-CoV-2 in outbreak settings. Eur Radiol. 2021 Jun; 31(6):4406.
    View in: PubMed
    Score: 0.237
  3. Generalized chest CT and lab curves throughout the course of COVID-19. Sci Rep. 2021 03 25; 11(1):6940.
    View in: PubMed
    Score: 0.234
  4. CT and clinical assessment in asymptomatic and pre-symptomatic patients with early SARS-CoV-2 in outbreak settings. Eur Radiol. 2021 May; 31(5):3165-3176.
    View in: PubMed
    Score: 0.228
  5. Apical periurethral transition zone lesions: MRI and histology findings. Abdom Radiol (NY). 2020 10; 45(10):3258-3264.
    View in: PubMed
    Score: 0.226
  6. Artificial intelligence for the detection of COVID-19 pneumonia on chest CT using multinational datasets. Nat Commun. 2020 08 14; 11(1):4080.
    View in: PubMed
    Score: 0.224
  7. Targeted early chest CT in COVID-19 outbreaks as diagnostic tool for containment of the pandemic-A multinational opinion. Diagn Interv Radiol. 2020 Jul; 26(4):292-295.
    View in: PubMed
    Score: 0.223
  8. Disposable Isolation Device to Reduce COVID-19 Contamination During CT Scanning. Acad Radiol. 2020 08; 27(8):1119-1125.
    View in: PubMed
    Score: 0.221
  9. Interreader Variability of Prostate Imaging Reporting and Data System Version 2 in Detecting and Assessing Prostate Cancer Lesions at Prostate MRI. AJR Am J Roentgenol. 2019 Mar 27; 1-8.
    View in: PubMed
    Score: 0.204
  10. Can computer-aided diagnosis assist in the identification of prostate cancer on prostate MRI? a multi-center, multi-reader investigation. Oncotarget. 2018 Sep 18; 9(73):33804-33817.
    View in: PubMed
    Score: 0.197
  11. Ultra-small superparamagnetic iron oxide contrast agents for lymph node staging of high-risk prostate cancer. Transl Androl Urol. 2018 Sep; 7(Suppl 4):S453-S461.
    View in: PubMed
    Score: 0.196
  12. Can Apparent Diffusion Coefficient Values Assist PI-RADS Version 2 DWI Scoring? A Correlation Study Using the PI-RADSv2 and International Society of Urological Pathology Systems. AJR Am J Roentgenol. 2018 Jul; 211(1):W33-W41.
    View in: PubMed
    Score: 0.192
  13. A Magnetic Resonance Imaging-Based Prediction Model for Prostate Biopsy Risk Stratification. JAMA Oncol. 2018 05 01; 4(5):678-685.
    View in: PubMed
    Score: 0.191
  14. "Super-active surveillance": MRI ultrasound fusion biopsy and ablation for less invasive management of prostate cancer. Gland Surg. 2018 Apr; 7(2):166-187.
    View in: PubMed
    Score: 0.190
  15. Prospective comparison of PI-RADS version 2 and qualitative in-house categorization system in detection of prostate cancer. J Magn Reson Imaging. 2018 11; 48(5):1326-1335.
    View in: PubMed
    Score: 0.190
  16. Risk of Upgrading from Prostate Biopsy to Radical Prostatectomy Pathology-Does Saturation Biopsy of Index Lesion during Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Biopsy Help? J Urol. 2018 04; 199(4):976-982.
    View in: PubMed
    Score: 0.188
  17. All over the map: An interobserver agreement study of tumor location based on the PI-RADSv2 sector map. J Magn Reson Imaging. 2018 08; 48(2):482-490.
    View in: PubMed
    Score: 0.188
  18. What Are We Missing? False-Negative Cancers at Multiparametric MR Imaging of the Prostate. Radiology. 2018 01; 286(1):186-195.
    View in: PubMed
    Score: 0.185
  19. 18F-DCFBC Prostate-Specific Membrane Antigen-Targeted PET/CT Imaging in Localized Prostate Cancer: Correlation With Multiparametric MRI and Histopathology. Clin Nucl Med. 2017 Oct; 42(10):735-740.
    View in: PubMed
    Score: 0.184
  20. Clinical impact of PSMA-based 18F-DCFBC PET/CT imaging in patients with biochemically recurrent prostate cancer after primary local therapy. Eur J Nucl Med Mol Imaging. 2018 Jan; 45(1):4-11.
    View in: PubMed
    Score: 0.183
  21. Prospective Evaluation of PI-RADS™ Version 2 Using the International Society of Urological Pathology Prostate Cancer Grade Group System. J Urol. 2017 09; 198(3):583-590.
    View in: PubMed
    Score: 0.178
  22. Differentiating Transition Zone Cancers From Benign Prostatic Hyperplasia by Quantitative Multiparametric Magnetic Resonance Imaging. J Comput Assist Tomogr. 2016 Mar-Apr; 40(2):218-24.
    View in: PubMed
    Score: 0.165
  23. Editorial comment. J Urol. 2013 Jan; 189(1):92.
    View in: PubMed
    Score: 0.131
  24. Documenting the location of systematic transrectal ultrasound-guided prostate biopsies: correlation with multi-parametric MRI. Cancer Imaging. 2011 Mar 29; 11:31-6.
    View in: PubMed
    Score: 0.117
  25. Federated semi-supervised learning for COVID region segmentation in chest CT using multi-national data from China, Italy, Japan. Med Image Anal. 2021 05; 70:101992.
    View in: PubMed
    Score: 0.058
  26. Preparation of a radiology department in an Italian hospital dedicated to COVID-19 patients. Radiol Med. 2020 Sep; 125(9):894-901.
    View in: PubMed
    Score: 0.056
  27. Predicting Gleason Group Progression for Men on Prostate Cancer Active Surveillance: Role of a Negative Confirmatory Magnetic Resonance Imaging-Ultrasound Fusion Biopsy. J Urol. 2019 01; 201(1):84-90.
    View in: PubMed
    Score: 0.050
  28. Incidental bladder cancers found on multiparametric MRI of the prostate gland: a single center experience. Diagn Interv Radiol. 2018 Sep; 24(5):316-320.
    View in: PubMed
    Score: 0.049
  29. Added Value of Multiparametric Magnetic Resonance Imaging to Clinical Nomograms for Predicting Adverse Pathology in Prostate Cancer. J Urol. 2018 11; 200(5):1041-1047.
    View in: PubMed
    Score: 0.048
  30. Follow-up of negative MRI-targeted prostate biopsies: when are we missing cancer? World J Urol. 2019 Feb; 37(2):235-241.
    View in: PubMed
    Score: 0.048
  31. Fusion prostate biopsy outperforms 12-core systematic prostate biopsy in patients with prior negative systematic biopsy: A multi-institutional analysis. Urol Oncol. 2018 Jul; 36(7):341.e1-341.e7.
    View in: PubMed
    Score: 0.048
  32. Targeted biopsy: benefits and limitations. Curr Opin Urol. 2018 03; 28(2):219-226.
    View in: PubMed
    Score: 0.047
  33. Ruling out clinically significant prostate cancer with negative multi-parametric MRI. Int Urol Nephrol. 2018 Jan; 50(1):7-12.
    View in: PubMed
    Score: 0.046
  34. Detection of prostate cancer in multiparametric MRI using random forest with instance weighting. J Med Imaging (Bellingham). 2017 Apr; 4(2):024506.
    View in: PubMed
    Score: 0.045
  35. Imaging and pathology findings after an initial negative MRI-US fusion-guided and 12-core extended sextant prostate biopsy session. Diagn Interv Radiol. 2014 May-Jun; 20(3):234-8.
    View in: PubMed
    Score: 0.036
  36. Current Ability of Multiparametric Prostate Magnetic Resonance Imaging and Targeted Biopsy to Improve the Detection of Prostate Cancer. Urol Pract. 2014 May; 1(1):13-21.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.